Recommendations for the prevention of aromatase inhibitor-associated bone loss in women with breast cancer

被引：3
|
作者：
Aapro, M. S. [1 ]
Hadji, P. [2 ]
Brufsky, A. [3 ]
Tubana-Hulin, M. [4 ]
Guise, T. [5 ]
Body, J. J. [6 ]
机构：
[1] Doyen IMO Clin De Genolier, Inst Multidisciplinaire Oncol, Genolier, Switzerland
[2] Univ Marburg, Dept Endocrinol & Reprod Med, Marburg, Germany
[3] Univ Pittsburgh, Dept Hematol Oncol, Pittsburgh, PA USA
[4] Ctr Rene Huguenin, Dept Oncol, St Cloud, France
[5] Univ Virginia, Dept Internal Med, Charlottesville, VA USA
[6] Univ Libre Bruxelles, Inst Jules Bordet, Brussels, Belgium
来源：
EJC SUPPLEMENTS | 2007年 / 5卷 / 04期
关键词：
D O I：
10.1016/S1359-6349(07)70769-3
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：186 / 186
页数：1
相关论文
共 50 条
  • [31] Pain and Sensitization in Women with Aromatase Inhibitor-Associated Arthralgias
    Crespo-Bosque, Monica
    Brown, Carrie
    Cartmel, Brenda
    Harrigan, Maura
    Irwin, Melinda
    Neogi, Tuhina
    [J]. ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [32] Aromatase Inhibitor-Associated Arthralgias
    Chlebowski, Rowan T.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (30) : 4032 - 4034
  • [33] BONE LOSS IN WOMEN WITH BREAST CANCER TREATED WITH AROMATASE INHIBITORS
    Zodelava, M.
    Tsikhiseli, G.
    Nijaradze, S.
    Tskhovrebashvili, N.
    Tatishvili, N.
    Tskhovrebashvili, M.
    Mamaladze, T.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2017, 28 : S465 - S465
  • [34] Frequency of zoledronic acid (ZOL) administration to prevent aromatase inhibitor-associated bone loss (AIBL)
    Lipton, A.
    Campbell-Baird, C.
    Chen, Y.
    Dias, R.
    Kelly, B.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [35] Emerging recommendations for the prevention of cancer treatment-induced bone loss in women with breast cancer
    Costa, L.
    Guise, T.
    [J]. EJC SUPPLEMENTS, 2009, 7 (02): : 304 - 304
  • [36] Aromatase inhibitor-associated musculoskeletal pain: taking 'AIM' at a symptom in breast cancer survivors
    Henry, N. Lynn
    [J]. PAIN MANAGEMENT, 2011, 1 (03) : 191 - 193
  • [37] A QUALITATIVE EXPLORATION OF THE IMPACT OF YOGA ON BREAST CANCER SURVIVORS WITH AROMATASE INHIBITOR-ASSOCIATED ARTHRALGIAS
    Galantino, Mary Lou
    Greene, Laurie
    Archetto, Benjamin
    Baumgartner, Melissa
    Hassall, Paula
    Murphy, Joanna Kluz
    Umstetter, Jamie
    Desai, Krupali
    [J]. EXPLORE-THE JOURNAL OF SCIENCE AND HEALING, 2012, 8 (01) : 40 - 47
  • [38] Impact of Yoga on Functional Outcomes in Breast Cancer Survivors With Aromatase Inhibitor-Associated Arthralgias
    Galantino, Mary Lou
    Desai, Krupali
    Greene, Laurie
    DeMichele, Angela
    Stricker, Carrie Tompkins
    Mao, Jun James
    [J]. INTEGRATIVE CANCER THERAPIES, 2012, 11 (04) : 313 - 320
  • [39] Exercise intervention in breast cancer patients with aromatase inhibitor-associated arthralgia: a pilot study
    DeNysschen, C. A.
    Burton, H.
    Ademuyiwa, F.
    Levine, E.
    Tetewsky, S.
    O'Connor, T.
    [J]. EUROPEAN JOURNAL OF CANCER CARE, 2014, 23 (04) : 493 - 501
  • [40] Prevention of aromatase inhibitor-induced bone loss in breast cancer with bisphosphonates:: Unexpected in vitro results
    Journe, F.
    Chaboteaux, C.
    Leclerq, G.
    Laurent, G.
    Body, J. -J.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2006, 17 : S68 - S68
12345